Is NCT02984852 results overdue?

Yes — results are overdue. Primary completion was 2017-02; the FDAAA-801 reporting deadline (2018-02-28) passed 3035 days ago and no results are posted on ClinicalTrials.gov.

Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants

NCT ID	NCT02984852 ↗
Sponsor	Janssen Scientific Affairs, LLC (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2017-02 (ACTUAL)
Reporting deadline	2018-02-28 (completion + 365d)
Days overdue	3035
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `2c5d1975e1fbada8…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02984852. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.